Overview

Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer

Status:
RECRUITING
Trial end date:
2031-11-30
Target enrollment:
Participant gender:
Summary
This is a prospective,single-arm,Phase II clinical study to designed to evaluate the efficancy and safety of nimotuzumab Combined with Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer
Phase:
PHASE2
Details
Lead Sponsor:
Tang-Du Hospital
Treatments:
130-nm albumin-bound paclitaxel
Carboplatin
Neoadjuvant Therapy
nimotuzumab
toripalimab